Results 111 to 120 of about 176,074 (266)

Encephalopathy with Hypothyroidism [PDF]

open access: yesJournal of the Royal Society of Medicine, 2004
Claire L, Warren, I M S, Sawhney
openaire   +2 more sources

Adverse Reactions Identified after Approval of Novel Medicines: Analysis of 339 New Molecular Entities and Therapeutic Biologics

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Postmarketing safety surveillance data identify safety issues not identified in preapproval clinical trials. We describe the frequency of new safety issues overall and by labeling section and the relationship of the most commonly added safety issues with the cumulative number of prescriptions dispensed via retail pharmacies.
Ellen Pinnow   +14 more
wiley   +1 more source

Secretopathies emerge as a new class of neurocristopathies

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Neural crest cells are a transient embryonic population of cells that give rise to a wide range of structures, including craniofacial cartilage and bone, peripheral neurons and glia, as well as components of the cardiac outflow tract, among others.
Amanda Teixeira   +3 more
wiley   +1 more source

The Challenge of Determining the Etiology of Encephalopathy in an Elderly Patient. [PDF]

open access: yesClin Case Rep
Ionescu VA   +9 more
europepmc   +1 more source

Cenobamate use in super‐refractory status epilepticus: A report of three cases

open access: yesEpileptic Disorders, EarlyView.
Abstract Objectives Super‐refractory status epilepticus (SRSE) is a neurological emergency with high morbidity and mortality. Cenobamate, a novel antiseizure medication, may be helpful in managing SRSE, but evidence is limited. Methods This retrospective case series reports the use of cenobamate as add‐on therapy in the management of three cases of ...
Marina Romozzi   +11 more
wiley   +1 more source

Beyond hypoxic-ischemic encephalopathy: genetic insights and precision diagnosis in neonatal encephalopathies. [PDF]

open access: yesFront Med (Lausanne)
Cimino C   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy